Journals / Kocatepe Tıp Dergisi / 2013 / Cilt: 14 - Sayı: 3

Koroner Arter Hastalarında Hipertansiyonun İnflamatuar Reaksiyona Additif Etkisi

Pages
129–134
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: When hs-CRP levels are compared the value of hsCRP in patients with CAD was found to be significantly increased (HR: 1.4 ± 0.8 mg / L , control: 0.7 ± 0.6 mg / L , p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Investigation about an additional contribution of hypertension (HT) to inflammatory process in stable coronary artery disease (CAD).
📊
Key Findings & Data:Group I only with CAD, Group II generated with patients with HT in addition to the CAD.
💡
Conclusion & Impact:Results: When hs-CRP levels are compared the value of hsCRP in patients with CAD was found to be significantly increased (HR: 1.4 ± 0.8 mg / L , control: 0.7 ± 0.6 mg / L , p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Koroner arter hastalığı · stabil angina · inflamatuar markerler

Abstract

Objective: Investigation about an additional contribution of hypertension (HT) to inflammatory process in stable coronary artery disease (CAD). Material and Methods: Patients were divided into three groups . Group I only with CAD, Group II generated with patients with HT in addition to the CAD. The control group was created with healthy volunteers of similar age group. hs-CRP, IL-1β, IL-6, IL-10 and TNF-α levels were measured. Results: When hs-CRP levels are compared the value of hsCRP in patients with CAD was found to be significantly increased (HR: 1.4 ± 0.8 mg / L , control: 0.7 ± 0.6 mg / L , p

Özet

Amaç: Stabil koroner arter hastalığında (KAH) hipertansiyonun (HT) inflamatuar sürece ilave katkısının olup olmadığını araştırmaktır. Gereç ve Yöntem: Hastalar üç gruba ayrıldı; Grup I sadece KAH olan, Grup II ise KAH’a ilaveten HT’si olan hastalardan oluşturuldu. Kontrol grubu benzer yaş grubunda sağlıklı gönüllülerden oluşturuldu. hs-CRP, IL-1β, IL-6, IL-10 ve TNFα’nın düzeyleri ölçüldü. Bulgular: hs-CRP değerleri karşılaştırıldığında, KAH grubunda hs-CRP değerinin anlamlı derecede artmış olduğu bulundu (KAH: 1.4±0.8 mg/L, Kontrol: 0.7±0.6 mg/L, p

🔖

Cite This Article

TANER, A. (2013). Koroner Arter Hastalarında Hipertansiyonun İnflamatuar Reaksiyona Additif Etkisi. Kocatepe Tıp Dergisi, Cilt: 14 - Sayı: 3, 129–134. https://ajindex.com/articles/205368

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Gordon T, Kannel WB. Premature mortality from coronary heart disease. The framingham study. JAMA 1971;215(10):1617-25.
  2. Choi H, Cho DH, Shin HH, Park JB. Association of high sensitivity C reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 2004;68(4):297-303.
  3. Gensini GF, Comeglio OM, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart Journal 1998;19(Suppl A):53-61.
  4. Pietri P, Vyssoulis G, Vlachopoulos C, et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 2006;24(11):2231-8. Frohlich ED. Potential mechanisms explaining the risk of left ventricular hypertrophy. Am J Cardiol 1987;59(2):91-7.
  5. Novo S, Abringnani MG, Corda M, Strano A. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment. Eur Heart J 1991;12(Suppl G):47-52.
  6. Farkas K, Kolossvary E, Jarai Z, Nemcsik J, Farsang C. Noninvasive assessment of microvascular endothelial function by laser doppler flowmetry in patients with essential hypertension. Atherosclerosis 2004;173(1):97- 102. Lekakis JP, Papathanassiou S, Papaioannou TG, et al. Oral L-arginine improves endothelial dysfunction in patients with essential hypertension. Int J Cardiol 2002;86(2-3):317-23. Burnett JC Jr. Coronary endothelial dysfunction in the hypertensive patient: from myocardial ischemia to heart failure. J Hum Hypertens 1997;11(1):45-9.
  7. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA 1997;94(26):14483-8.
  8. Mervaala EM, Müller DN, Park JK, et al. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 1999;33(1 Pt 2):389-95.
  9. Dörffel Y, Lätsch C, Stuhlmüller B, et al. Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension 1999;34(1):113-7.
  10. Puddu P, Puddu GM, Zaca F, Muscari A. Endothelial dysfunction in hypertension. Acta Cardiol 2000;55(4):221- 32. Lemarie CA, Esposito B, Tedgui A, Lehoux S. Pressure induced vascular activation of nuclear factor-kappa B: role in cell survival. Circ Res 2003;93(3):207-12.
  11. Renaudin C, Bataillard A, Sassard J. Partial transfer of genetic hypertension by lymphoid cells